content. l Fat peroxidation is in itself a branching chain reaction that provides a steady supply of free radicals (FR), which may induce cell C. VERDEJO, P. MARCO, J. RENAU-PIQUERAS, M.D. PINAZO-DURAN damage and death? Although molecular oxygen tetravalent reduction is the most common aerobic metabolism reaction, oxygen reactive forms are produced in many physiological and pathological metabolic pathways?,4 Between these reactive compounds FR are generated when an oxygen atom loses one electron, thus becoming negatively charged and very unbalanced. It is then prone to capture another electron from a neighbouring molecule in order to balance its thermodynamic and structural stability, creating new FR. Superoxide anion (02-") is the first oxygen FR produced and may be followed by its protonated form, the perhydroxyl radical (02-' + H+ = H02) Hydrogen peroxide (02-' + O2-' + 2H+ = H202 + O2) in the presence of iron leads to formation of the hydroxyl radical (H202 + O2 + Fe 2 + = OH-+ OR" + Fe02), the most deleterious FR for cells and tissues. The hazardous effects of FR can be evaluated by detecting and quantifying the reaction by-products in the tested tissue, such as dienes, hydrogen peroxide, lipid peroxides, alkanes and aldehydes.5 Endogenous malondialdehyde (MDA) derives from PFA 6 with three or more double bonds and repres�nts their peroxidation level. 4-Hydroxynonenal (4-HNE), the major representative of 4-hydroxyalkenals, is the main product formed from omega 6-PFA? Nowadays it is well known that lipid peroxidation (LPO) is one of the reactions set into motion as a result of FR generation in the body that mediates tissue damage and diseases. There are intracellular and extracellular enzymatic and non-enzymatic defence mechanisms against oxidative attack that are involved in reducing or compensating FR formation. The simplest way to compensate the pro-oxidant domain is to increase the levels of antioxidants usually found in the body, including superoxide dismutase (SOD) and catalase (CAT).1, 2 ,5 Their enzymatic activities are the most relevant data in assessing both the oxidative status and tissue injury. Nevertheless, the imbalance between pro-and antioxidant sources is the origin of oxidative stress to cells and tissues.
. Therefore, studies on LPO are needed in eye dIseases to establish some biochemical concepts and pathogenetic mechanisms. These data could be particularly important in assessing the initial steps, as well as the long-lasting changes, occurring in the course of proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR), which are the object of our investigations. The present study was designed to obtain vitreous samples from patients who were operated on for established PVR and PDR. A comparison group was formed of vitreous samples from eyes with non-fibrous or vascular vitreoretinal proliferation. The biomedical evidence of FR formation and their reactive metabolites is presented herein as the preliminary results of lipid peroxide determination in the most prevalent vitreoretinal diseases, by analysing MDA and 4-HNE levels using both the thiobarbituric acid reactive substances (TBARS) and LPO 586 tests. The antioxidant status was also determined in the vitreous by analysing SOD and CAT activities.
Materials and methods
Forty-five patients were initially selected for this study. All procedures conformed to the European Community guidelines for clinical trials and human research. Forty one vitreous samples from patients ranging in age from 26 to 78 years were finally included (44% males, 56% females). The mean age was similar in the three study groups. We analysed FR production in 41 vitreous samples obtained during standard three-port 'pars plana' vitrectomies performed on eyes with PVR (n = 12) or PDR (n = 15). A comparison group of vitreous samples (CG; n = 14) included patients with rhegmatogenous retinal detachment or epiretinal membrane and/or macular hole cases. Vitrectomies were performed with an Ocutome STTO (Alcon Surgical). One thousand millilitres of vitreous was obtained from each patient before the infusion opening and was introduced into individual cryo-Eppendorf tubes. Four aliquots were separated from each vitreous and stored at -70°C until processing. Samples were sonicated without any pattern dilution and processed for five biochemical techniques: protein concentration, basal and induced LPO (BLPO and ILPO, respectively) and the antioxidant activity for SOD and CAT. Protein determination was assayed by using the Bio-Rad assay with the bicinchoninic acid reagent, as described,8.9 and the results were expressed as the mean ± SD for two to four different experiments.
A TBA 10 assay that analyses a whole range of agents, including secondary peroxidation products, was carried out. TBARS include malondialdehyde dimetilacetal 1,l,3,3-tetrametoxypropano (MDA) content and MDA like metabolites. The method is based on aldehyde butanol extraction by TBA and synchronised measurement of the corresponding fluorescence emission. The reaction mixture absorbance was measured at 590 nm on a cytofluor against a blank containing the reagents but not the vitreous samples. Assays were repeated three to five times and the values given are the mean ± SD for three measurements per experiment, as previously.u We analysed the BLPO by adding to 50 "Ll of each sample Tris maleic buffer KCI 5 mM pH 7.4, bidistilled water and EDTA 10 mM. After incubation at 37°C, SDS and KCl 0.1 N were also added. A mixture of diluted 2% and 20% MDA in phosphate buffer, phosphotungstic acid and TBA was finally introduced in boiling water for 60 min. After cooling, butanol extraction was carried out by adding 1 ml of n-butanol to the samples, vigorously mixing and performing the centrifugation of the specimens at 2.800 g for 10 min at 25°C. Floating butanol layers were obtained and three samples of each processed vitreous body were deposited in a microtitre to measure emission at 590 nm in a cytofluor. Standard curves of MDA were assayed in paralleL The mean value for each determination was obtained and the data were processed using a BASIC program developed in our laboratory. 1 2 Values were expressed as nanomoles per milligram protein.
ILPO was studied by means of an NADPH-iron system composed of a mixture of NADPH 40 mM, FeCl 3 10 mM, ADP 45 mM, which was added to the vitreous samples (50 flol) immersed in Tris maleic KCl 50 mM pH 7.4 and bidistilled water to induce lipid hydroperoxide formation. MDA resulting from ILPO was assayed and measured as above. The peroxidic aldehydic product 4-HNE was assayed by the LPO 586 method purchased from Bioxytech (France),13.14 which involves a chromogenic reagent that reacts with 4-HNE at 45°C when 100% methanol is added. One aliquot of each vitreous body was incubated at 45 °C for 40 min in a mixture of commercialised reagents (R1: 11.4 mM acetonitrile; R2: 10.4 mM metanolsulfonil acid). The synchronised measurement of emission was performed on a Perkins-Elmer LS50B spectrofluorimeter (586 nm absorbance) against a blank containing all the reagents except the vitreous samples. The mean values ± SD were obtained by interpolating with standard curves developed in parallel using a BASIC program, as described above, and were expressed as nanomoles per milligram protein.
The antioxidant defence status was determined by assaying SOD and CAT enzymatic activities. SOD activity was measured by an adaptation of the method described by Bensinger and Johnson15 for eye tissues, and the technique used by Paoletti and Mocali. 16 The method employed was based on the ability of SOD to inhibit a superoxide-driven reaction. It is a simple chemical reaction sequence that generates superoxide from molecular oxygen in the presence of EDTA, Mn, Cl and mercaptoethanoL The reagents used were triethanolamine 100 mM and diethanolamine 100 mM in HCI buffer (TDB pH 7.4), NADPH 7.5 mM, EDTA 100 mM and MnCb 50 mM pH 7, and mercaptoethanol 10 mM. NADPH oxidation is linked to the availability of superoxide anions in the vitreous samples. SOD is added to the mixture and brings about the inhibition of nucleotide oxidation. This technique relies on the oxidation of NAPPH and the corresponding measurement was spectrophotometric ally accomplished. The results were expressed as the mean ± SD for three or four experiments, as Units per milligram protein.
CAT activity was determined by the technique absorbance per time unit is a measure of the CAT described by Aebi/7 taking into account the catalytic (not activity. As a reference range, the catalase activity in the peroxidative) activity of catalase that can be blood of normal subjects was found to be 313 ± 96 k/ g measured by following the decomposition of H202. The with respect to haemoglobin content. Data were samples were diluted in phosphate buffer pH 7.0 (2 ml) expressed as the mean ± SD for three or four and the reaction was started by addition of H202 (1 ml Results Table 1 describes origin of the samples and the characteristics of the patients. BLPO, analysed by TBARS and expressed in MDA values (nanomol/mg tissue protein) was: 56 ± 9 in the CG, 92 ± 10 in the PVR eyes and 94 ± 15 in the PDR patients. Statistically significant differences between the PVR eyes and the CG (p � 0.0001) and between the PDR eyes and the CG (p � 0.0001) were noted, as shown in Fig. 1 . 4-HNE determination also displayed significantly greater values in the PVR and PDR groups than in the CG (p � 0.0001) ( Table 2) .
Data from the ILPO, analysed by TBARS and using an NADPH-Fe dependent system, were: 294 ± 61 in the CG, 473 ± 73 in the PVR eyes and 472 ± 66 in the PDR patients. Statistically significant differences between the PVR and CG cases (p � 0.0001) and between the PDR and CG groups (p � 0.0001) were observed. However, no significant differences were found between the PVR and PDR groups, despite the fact that the individual values were significantly higher than in the CG (Fig. 2) . When compared with the BLPO, the ILPO also showed 5-fold higher MDA mean values (294 ± 61 vs 56 ± 9 nmol/mg protein in the CG, p � 0.0001; 473 ± 73 vs 92 + 10 nmol/ mg protein in PVR, p � 0.0001; and 472 ± 66 vs 94 ± 15 nmol/mg protein in PDR, p � 0.0001).
The average SOD activity displayed significantly smaller values in the vitreous samples from patients suffering from PVR and PDR than in the CG (p = 0.0010 and p � 0.0001, respectively), as shown in Fig. 3 .
When CAT activity was tested, the average values were significantly higher in the vasoproliferative and fibroproliferative vitreoretinopathies than in the retinal detachment/ epiretinal membranes/macular hole vitreous samples (p � 0.0001), as expressed as mU /mg protein (Fig. 4) . The relationship between SOD and CAT activity was also analysed and the values displayed significant differences in the CG versus the PVR group (p = 0.0035) and in the CG versus the PDR group (p = 0.005).
Discussion
Our data on BLPO showed significantly higher values of MDA and MDA-like metabolites in the PVR and PDR groups than in the comparison eyes, on the TBA test. Similar results were reported by Augustin et al.IS who analysed the MDA content in the vitreous body of patients suffering from PDR. These data are also in agreement with the preliminary experiments from PVR and PDR eyes that were carried out in our laboratoryY Controversial reports have emerged over the past few years about the reliability of the TBA test. 1 2 ,19 Because of this, we additionally determined the 4-HNE content using the LPO 586 technique, a new assay recently introduced in the field of biotechnology. There were significantly higher values of this cytotoxic 4-hydroxyalkenal in the vitreous samples from patients suffering from vasoproliferative and fibroproliferative disorders than in the comparison eyes. In the latter, oxidative activity was also detected, probably as a consequence of the surgical approach, and a threshold of oxidative stress as could be expected in these pathological eyes,z° As a result of the present study we suggest that the TBARS and LPO 586 tests are valid to establish an index of human vitreous body vulnerability to lipid peroxidation. The results with respect to each proliferative group, as shown in Table 2 and Figs. 1 and 2 , are fairly similar. However, the lack of significant differences in FR formation between these PVR and PDR groups requires further research. Because of this, data for each pathology deserve separate discussion. From a biological viewpoint, in diabetes and other conditions in which cellular homeostasis is altered, chorioretinal hypoxia is the result of a series of cellular changes26 induced in situ by the metabolic disorder. This strongly suggests that the mechanisms of ischaemia -reperfusion create an adequate environment for FR generation and the expression of cytokines and other related molecules}7,28 leading to the progression of the vitreoretinopathy. Increased LPO was significantly detected in our group of diabetic patients in whom we had previously observed ocular fundus complications, as compared with non diabetic individuals of similar ages. In the pathogenesis of the fibroproliferative processes, inflammation is the most relevant stage at which lipid peroxide formation can be involved,z2,28-30 It would be explained in two steps: (1) the aetiological agent causes inflammation and the underlying polynuclear neutrophil activation, (2) proteases induce FR formation via xanthin oxidase. The release of cytokines has been detected in PVR eyes and cytokines are also involved in the mechanisms of modulating the process, acting as chemotactic stimuli for inflammatory cells and fibroblasts. The cells change their apparent phenotype becoming the primary source of collagens and other extracellular matrix proteins,z2,24 These phenomena might lead to the genesis of membranes and tractional bands between the retina and hyaloid, which may induce tears and retinal detachments,z9,3o The results of the present study may agree with this hypothesis. This emphasises the importance of FR in the initial steps as well as in the evolution of this disease.
SOD is the main chain-breaking antioxidant, which acts in the aqueous phase by trapping 0 2 -·,z, 31 We have described significant differences in global SOD activity in the PVR and PDR groups as compared with the controls. We did not discriminate between the Cu-Zn and Mn forms of SOD. However, total SOD activity displayed an important decrease in activity in the vitreous body from patients with PVR and PDR relative to the comparison group. Moreover, it is important to point out that CAT also showed significantly lower activity in the pathological eyes as a result of retinal proliferative phenomena. An important age-related decrease in the activity of antioxidant enzymes in the eyes has previously been described.32,33 In our study, in spite of individual differences, the mean age was quite similar between the groups with proliferative and non proliferative disease (see Table 1 , Figs. 3 and 4) . The signal for the production and reactions of FR induces the formation and transport of the appropriate antioxidant to the right site. This signal might be altered in patients with advanced PVR and PDR and the imbalance between oxidative and antioxidative systems may trigger the cell and tissue damage occurring in these eyes? 4 Taken together, our results strongly suggest that FR formation substantially increases as a result of inflammation and ischaemia-reperfusion occurring in eyes suffering from established PVR and PDR. We suggest that both mechanisms, acting at a time when FR formation and antioxidant defences become imbalanced, in the presence of iron, may trigger lipid hydroperoxide production, cell and tissue damage and death, and could lead to other molecular events involving cytokines, extracellular matrix components and diverse regulatory molecules that inexorably determine the progression of these diseases. Since FR formation and their deleterious effects on biomolecules can be avoided, or at least diminished, by blockage and removal of reactive oxygen elements, and this could be achieved by antioxidant enzymes and scavengers, further research on this possible therapeutic approach to PVR and PDR is needed. This in turn will allow more effective treatment of these damaging diseases that irreversibly lead to visual impairment in affected patients.
